Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Novartis biosimilar blocked by US court

Swiss firm’s Neupogen copy has its injunction upheld at appeal

- PMLiVE

EMA clears Novartis’ lung cancer drug Zykadia

First treatment option in Europe for patients with ALK-postitive NSCLC

- PMLiVE

GSK shelves ViiV sale as it lays out growth strategy

Firm now bullish on the HIV joint pharma project’s prospects

EU flag

EMA to stop ‘revolving doors’ committee members

Comes nearly five years after its former director left for a pharma service firm

- PMLiVE

Heart drug sales continue downward spiral

But revenue has stabilised after a tough three years of patent expiries

- PMLiVE

Alexion boosts rare disease portfolio with $8.4bn Synageva buy

Deal will help bolster firm's offering which is currently headed by aHUS drug Soliris

- PMLiVE

GSK files immune deficiency gene therapy in Europe

Therapy designed to correct ADA deficiency 

- PMLiVE

Schultz takes Lundbeck helm after leaving Novo Nordisk

Former executive left Danish firm just days ago

- PMLiVE

China to relax pricing curbs from June

Reports suggest medicine sales could reach $185bn in the region by 2018

Shire Basingstoke

Shire enters research partnership for rare eye disease

Will work with Foundation Fighting Blindness on treatment for adRP

- PMLiVE

Cancer drug spend tops $100bn in 2014

But payers are starting to bulk at increasing prices

- PMLiVE

Baxter and Merrimack file pancreatic cancer drug in EU

MM-398 is thought to help direct the active drug into tumours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links